Compass Wealth Management LLC Decreases Stock Holdings in HCA Healthcare, Inc. $HCA

Compass Wealth Management LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 95.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 550 shares of the company’s stock after selling 12,197 shares during the quarter. Compass Wealth Management LLC’s holdings in HCA Healthcare were worth $234,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Park Place Capital Corp increased its holdings in shares of HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares in the last quarter. Cerity Partners LLC raised its holdings in shares of HCA Healthcare by 13.1% in the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after buying an additional 5,092 shares during the last quarter. Swiss National Bank increased its position in shares of HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after acquiring an additional 23,100 shares during the period. Cherokee Insurance Co acquired a new stake in HCA Healthcare during the 2nd quarter worth about $3,869,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in shares of HCA Healthcare by 4.2% in the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 297,300 shares of the company’s stock worth $126,709,000 after purchasing an additional 11,900 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $506.29 on Wednesday. The business’s 50 day moving average price is $480.84 and its 200-day moving average price is $435.90. The firm has a market capitalization of $115.53 billion, a price-to-earnings ratio of 19.57, a price-to-earnings-growth ratio of 1.30 and a beta of 1.36. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $527.55.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s revenue was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q4 EPS beat and solid operational performance: HCA reported $8.01 EPS vs. consensus ~ $7.37, driven by strong patient volumes and higher revenue per equivalent admission—this beat is the primary catalyst for the rally. HCA Healthcare (HCA) Beats Q4 Earnings Estimates
• Positive Sentiment: Big capital returns: HCA raised the quarterly dividend ~8.3% to $0.78 and authorized an additional $10 billion for buybacks — increases near-term shareholder cash returns and supports the stock. HCA Healthcare Raises Dividend by 8.3%, Adds $10 Billion to Stock Buyback
• Positive Sentiment: FY2026 profit outlook and cost savings: Management reiterated FY2026 EPS guidance (29.10–31.50) roughly in line with Street and outlined a $400M cost-savings plan that it says will boost profit—supporting forward earnings expectations. HCA Healthcare forecasts 2026 profit above estimates on medical care services demand
• Neutral Sentiment: Revenue slightly missed estimates: Q4 revenue was $19.51B vs. the ~$19.67B consensus—top-line growth was positive (+6.7% YoY) but slightly below Street expectations, which tempers the beat. HCA Healthcare earnings press release / transcript
• Neutral Sentiment: Management says it can navigate policy uncertainty, but the outlook depends on execution and payer developments. Why HCA says it can navigate 2026 policy uncertainty
• Negative Sentiment: Policy headwinds: HCA flagged roughly a $1 billion hit tied to the loss of ACA premium tax credit flow-through and Medicaid changes—this is a material near-term headwind to revenue/margins. HCA expects $1 billion hit from loss of ACA tax credits, Medicaid changes
• Negative Sentiment: Analyst caution on valuation and margin sustainability: Some analysts warn margins may be peaking and HCA’s valuation now reflects much of the improvement, noting downside risk if policy pressures or margin compression accelerate. HCA Healthcare: A Booming Buyback But Risks Loom (Downgrade)

Wall Street Analyst Weigh In

HCA has been the subject of a number of recent research reports. KeyCorp reissued an “overweight” rating and set a $500.00 price target on shares of HCA Healthcare in a research report on Thursday, January 22nd. Mizuho boosted their target price on shares of HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a research report on Thursday, December 18th. UBS Group boosted their price objective on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research report on Monday, October 27th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and set a $503.00 target price on shares of HCA Healthcare in a report on Tuesday, January 6th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $488.75.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.30% of the stock is currently owned by company insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.